Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
16.64M 21.34M 18.81M 23.16M 18.35M 26.49M 25.21M 23.52M 21.41M 21.22M 18.85M 17.89M 16.89M 16.16M 13.48M 13.07M 12.21M
Cost of Revenue
6.77M 6.96M 7.09M 9.78M 9.97M 11.74M 9.94M 11.4M 9.12M 9.17M 7.95M 7.55M 6.8M 5.93M 5.02M 4.94M 4.81M
Gross Profit
9.87M 14.39M 11.72M 13.39M 8.38M 14.75M 15.28M 12.12M 12.29M 12.05M 10.91M 10.34M 10.1M 10.23M 8.45M 8.13M 7.41M
Operating Income
-13.41M -5.71M -8.35M -11.08M -17.04M -8.82M -11.55M -19.24M -17.21M -17.09M -16.3M -17.46M -15.35M -16.78M -10.74M -6.38M -5.4M
Interest Income
313K 380K 521K 668K 937K 913K 1.07M 737K 765K 564K 136K 54K 22K n/a n/a n/a n/a
Pretax Income
-15.6M -8.21M -10.49M -13.1M -23.42M -10.82M -12.9M -20.79M -18.77M -18.9M -17.85M -17.39M -16.38M -17.79M -11.63M -5.57M -8.09M
Net Income
-15.65M -8.2M -10.53M -13.15M -23.48M -10.8M -12.92M -20.8M -18.8M -18.88M -17.87M -17.5M -16.4M -17.67M -11.62M -5.56M -8.08M
Selling & General & Admin
17.58M 15.69M 14.67M 19.09M 19.86M 18.9M 19.02M 22.71M 21.76M 20.95M 19.92M 20.59M 18.19M 19.05M 13.72M 10.07M 8.18M
Research & Development
5.56M 4.43M 4.47M 5.29M 5.55M 4.67M 5.17M 6.27M 5.77M 6.43M 5.47M 5.6M 5.71M 5.56M 4M 2.95M 3.19M
Other Expenses
n/a -16K 927K 88K -161K -5K -185K -105K 1.97M 1.76M 1.81M 1.62M 1.54M -166K -126K -52K -66K
Operating Expenses
23.14M 20.12M 20.07M 24.38M 25.42M 23.57M 24.19M 30.83M 29.5M 29.14M 27.2M 27.8M 25.45M 25.98M 18.97M 14.11M 12.38M
Interest Expense
2.49M 2.59M 2.63M 2.61M 2.61M 2.29M 2.24M 2.17M 2.05M 1.85M 1.11M 849K 749K 844K 763K 757K 751K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
29.91M 27.07M 27.16M 34.16M 35.39M 35.31M 34.13M 42.23M 38.62M 38.31M 35.15M 35.36M 32.25M 31.91M 23.99M 19.05M 17.19M
Income Tax Expense
-48K -8K 44K 47K 63K -22K -15K 18K 29K -26K 21K 106K 22K -117K -11K -6K -6K
Shares Outstanding (Basic)
49.66M 49.56M 49.5M 49.42M 49.19M 49.09M 48.98M 40.64M 38.33M 38M 37.9M 37.61M 37.46M 37.25M 37.16M 29.97M 35.69M
Shares Outstanding (Diluted)
49.66M 49.56M 49.5M 49.42M 49.19M 49.09M 48.98M 40.64M 38.33M 38M 37.9M 37.61M 37.46M 37.25M 37.16M 29.97M 35.69M
EPS (Basic)
-0.32 -0.17 -0.21 -0.27 -0.48 -0.22 -0.26 -0.51 -0.49 -0.5 -0.47 -0.47 -0.44 -0.47 -0.31 -0.19 -0.23
EPS (Diluted)
-0.32 -0.17 -0.21 -0.27 -0.48 -0.22 -0.26 -0.51 -0.49 -0.5 -0.47 -0.47 -0.44 -0.47 -0.31 -0.19 -0.23
EBITDA
-13.41M -3.77M -6.04M -8.57M -18.76M -6.42M -8.09M -16.52M -14.6M -15.15M -14.8M -14.85M -14.01M -15.57M -9.62M -3.68M -6.33M
EBIT
n/a -5.62M -7.86M -10.5M -20.81M -8.53M -10.66M -18.61M -16.72M -17.05M -16.74M -16.54M -15.63M -16.95M -10.87M -4.81M -7.34M
Depreciation & Amortization
n/a 2.09M 1.82M 1.93M 2.05M 2.11M 2.58M 2.09M 2.12M 1.9M 1.94M 1.69M 1.62M 1.37M 1.24M 1.13M 1.01M